BDAZ - That is the challenge we have as a First In Class drug in a double blinded trial. The good news is that the impact of potential good news from this trial could be very significant. At that time Rishi Puri may dig into some old notes so that he can be on the right side of some new technology.

March 2014 was a long time ago. There has likely been a number of trials that Rishi has participated in since then and he just plain forgot about this little company and this new technology that up to this point has no traction.

tada